Articles with public access mandates - Ala AbudayyehLearn more
Not available anywhere: 2
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients
A Abudayyeh, A Hamdi, M Abdelrahim, H Lin, VD Page, G Rondon, ...
Transplant Infectious Disease 19 (1), e12632, 2017
Mandates: US National Institutes of Health
Cancer immunotherapy and its renal effects
O Mamlouk, A Abudayyeh
Journal of Onco-Nephrology 3 (3), 151-159, 2019
Mandates: US National Institutes of Health
Available somewhere: 37
Clinical features and outcomes of immune checkpoint inhibitor–associated AKI: a multicenter study
FB Cortazar, ZA Kibbelaar, IG Glezerman, A Abudayyeh, O Mamlouk, ...
Journal of the American Society of Nephrology 31 (2), 435-446, 2020
Mandates: US National Institutes of Health
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
N Abdel-Wahab, H Safa, A Abudayyeh, DH Johnson, VA Trinh, ...
Journal for immunotherapy of cancer 7, 1-10, 2019
Mandates: US National Institutes of Health
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
O Mamlouk, U Selamet, S Machado, M Abdelrahim, WF Glass, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
Mandates: US National Institutes of Health
Nuclear receptor 4A (NR4A) family–orphans no more
S Safe, UH Jin, B Morpurgo, A Abudayyeh, M Singh, RB Tjalkens
The Journal of steroid biochemistry and molecular biology 157, 48-60, 2016
Mandates: US National Institutes of Health
Acute kidney injury in patients treated with immune checkpoint inhibitors
S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ...
Journal for immunotherapy of cancer 9 (10), 2021
Mandates: US National Institutes of Health
Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3, 11‐dioxo‐18β‐olean‐1, 12‐dien‐30‐oate in colon cancer cells
S Chintharlapalli, S Papineni, M Abdelrahim, A Abudayyeh, I Jutooru, ...
International journal of cancer 125 (8), 1965-1974, 2009
Mandates: US National Institutes of Health
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors
V Nair, S Sreevalsan, R Basha, M Abdelrahim, A Abudayyeh, AR Hoffman, ...
Journal of Biological Chemistry 289 (40), 27692-27701, 2014
Mandates: US National Institutes of Health
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ...
Kidney international 100 (1), 196-205, 2021
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met
S Papineni, S Chintharlapalli, M Abdelrahim, S Lee, R Burghardt, ...
Carcinogenesis 30 (7), 1193-1201, 2009
Mandates: US National Institutes of Health
Paraprotein–related kidney disease: evaluation and treatment of myeloma cast nephropathy
KW Finkel, EP Cohen, A Shirali, A Abudayyeh
Clinical Journal of the American Society of Nephrology 11 (12), 2273-2279, 2016
Mandates: US Department of Veterans Affairs
Nuclear receptor 4A1 (NR4A1) as a drug target for renal cell adenocarcinoma
E Hedrick, SO Lee, G Kim, M Abdelrahim, UH Jin, S Safe, A Abudayyeh
PLoS One 10 (6), e0128308, 2015
Mandates: US National Institutes of Health
Renal toxicities of novel agents used for treatment of multiple myeloma
R Wanchoo, A Abudayyeh, M Doshi, A Edeani, IG Glezerman, D Monga, ...
Clinical Journal of the American Society of Nephrology 12 (1), 176-189, 2017
Mandates: US National Institutes of Health
Symptomatic BK virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients
A Abudayyeh, A Hamdi, H Lin, M Abdelrahim, G Rondon, BS Andersson, ...
American Journal of Transplantation 16 (5), 1492-1502, 2016
Mandates: US National Institutes of Health
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis
JS Lin, O Mamlouk, U Selamet, A Tchakarov, WF Glass, RA Sheth, ...
Oncoimmunology 10 (1), 1877415, 2021
Mandates: US National Institutes of Health
Transplant oncology: an evolving field in cancer care
M Abdelrahim, A Esmail, A Abudayyeh, N Murakami, A Saharia, ...
Cancers 13 (19), 4911, 2021
Mandates: US National Institutes of Health
The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression
X Liu, M Abdelrahim, A Abudayyeh, P Lei, S Safe
Molecular cancer therapeutics 8 (5), 1207-1217, 2009
Mandates: US National Institutes of Health
Third-party BK virus-specific cytotoxic T lymphocyte therapy for hemorrhagic cystitis following allotransplantation
A Olson, R Lin, D Marin, H Rafei, MH Bdiwi, PF Thall, R Basar, ...
Journal of Clinical Oncology 39 (24), 2710-2719, 2021
Mandates: US National Institutes of Health
Checkpoint inhibitor-related renal vasculitis and use of rituximab
O Mamlouk, JS Lin, M Abdelrahim, AS Tchakarov, WF Glass, U Selamet, ...
Journal for immunotherapy of cancer 8 (2), 2020
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program